FDA decision: Lorundrostat by Mineralys Therapeutics (on or before December 22, 2026)
If the FDA's decision on Lorundrostat by Mineralys Therapeutics on or before December 22, 2026 is a full approval or an accelerated approval, the answer is Yes.
What's your call?
Nobody has called this yet. Yours could be the first. Voting closes Dec 23.
Question and outcome: Kalshi. CallItPoll is not affiliated with Kalshi and runs no betting or trading.